Araştırma Makalesi

Investigation of Seroprevalence of Vaccine-Preventable Diseases in Medical School Students

Cilt: 9 Sayı: 3 20 Aralık 2025
PDF İndir
EN TR

Investigation of Seroprevalence of Vaccine-Preventable Diseases in Medical School Students

Öz

Objective: Medical students are in the high-risk group regarding exposure to infectious diseases during their education. This study aimed to evaluate the seroprevalence of hepatitis A, hepatitis B, measles, rubella, mumps, mumps, and varicella viruses among the vaccine-preventable infectious diseases in the fourth, fifth and sixth-grade students of the Faculty of Medicine of our university. Methods: The serologic tests performed for hepatitis A, hepatitis B, measles, rubella, mumps, mumps, and varicella in fourth, fifth, and sixth-grade students studying at the Faculty of Medicine in the 2024-2025 academic year were retrospectively analyzed. Student records were scanned retrospectively through the hospital information processing system, and HBsAg, Anti-HBs, Anti-HAV IgG, measles IgG, Rubella IgG, mumps IgG, and varicella IgG results performed between 01.10.2021-31.12.2024 were recorded. Data were analyzed with IBM SPSS for the Mac 26.0 program. (Armonk, NY: IBM Corp, USA) Results: The mean age of 317 students was 22.5 ± 1.5 years; 47.6% were female and 52.4% were male. HBsAg, anti-HCV, and anti-HIV tests were negative in all students. Anti-HBs positivity was 71%, anti-HAV IgG positivity was 44%, measles IgG positivity was 67%, rubella IgG positivity was 98%, mumps IgG positivity was 88%, and varicella IgG positivity was 95%. The presence of incomplete vaccinations in final-year students was striking. Conclusion: It is observed that the immunity levels of medical students against vaccine-preventable diseases are not at the desired level. Serologic screening of students before starting practical training and vaccinating those with deficient immunity is essential for protecting students and the patient population.

Anahtar Kelimeler

Kaynakça

  1. 1. World Health Organzaton (WHO). Global hepatts report 2024: acton for access n low- and mddle-ncome countres. Geneva: Last accessed date:: 24.01.2025. Avalable from: https://www.who.nt/publcatons//tem/9789240091672.
  2. 2. Centers for Dsease Control and Preventon. Recommended Vaccnes for Healthcare Workers. Last accessed date: 24.01.2025. Avalable from: https://www.cdc.gov/vacc- nes-adults/recommended-vaccnes/ndex.html.
  3. 3. Von Lnstow ML, Yde Nelsen A, Krkby N, et al. Immunty to vaccne-preventable dseases among paedatrc healthcare workers n Denmark, 2019. Euro Survell. 2021;26(17):2001167. do: 10.2807/1560-7917.ES.2021.26.17.2001167.
  4. 4. Han SB, Park SH, Y Y, et al. Measles seroprevalence among healthcare workers n South Korea durng the post-elmnaton perod. Hum Vaccn Immunother. 2021;3;17(8):2517- 2521. do: 10.1080/21645515.2021.1888623.
  5. 5. Gavola GC, Desa S. Immunzaton requrements n medcal school accredtaton standards. Vaccne. 2024;42(4):753-756. do:10.1016/j.vaccne.2023.04.026.
  6. 6. World Health Organzaton. Vaccnaton n acute humantaran emergences: a framework for decson makng. Last accessed date: 24. 06.12.2024. Avalable from: http:// apps.who.nt/rs/btstream/10665/92462/1/WHO_IVB_13.07_eng.pdf.
  7. 7. Tekn Yılmaz A. Chldhood Routne Vaccne Schedule and Immunzaton Practces. J Botechnol and Strategc Health Res. December 2024;8(3):148-162. do:10.34084/ bshr.1576419
  8. 8. Babaoglu B, Fdancı I, Aksoy H, Ayhan Baser D. Evaluaton of hepatts A, hepatts B, hepat ts C, HIV, mumps, measles, rubella, and varcella mmunty status of health scences students. Interdscp Med J. 2024;15(53):137-43.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Bulaşıcı Hastalıklar

Bölüm

Araştırma Makalesi

Erken Görünüm Tarihi

15 Aralık 2025

Yayımlanma Tarihi

20 Aralık 2025

Gönderilme Tarihi

26 Ağustos 2025

Kabul Tarihi

29 Eylül 2025

Yayımlandığı Sayı

Yıl 2025 Cilt: 9 Sayı: 3

Kaynak Göster

APA
Altunçekiç Yildirim, A., Işikli, Ş., Kurt, C., & Öztürk Çerik, H. (2025). Investigation of Seroprevalence of Vaccine-Preventable Diseases in Medical School Students. Journal of Biotechnology and Strategic Health Research, 9(3), 169-174. https://doi.org/10.34084/bshr.1760448
AMA
1.Altunçekiç Yildirim A, Işikli Ş, Kurt C, Öztürk Çerik H. Investigation of Seroprevalence of Vaccine-Preventable Diseases in Medical School Students. J Biotechnol and Strategic Health Res. 2025;9(3):169-174. doi:10.34084/bshr.1760448
Chicago
Altunçekiç Yildirim, Arzu, Şeyma Işikli, Celali Kurt, ve Hatun Öztürk Çerik. 2025. “Investigation of Seroprevalence of Vaccine-Preventable Diseases in Medical School Students”. Journal of Biotechnology and Strategic Health Research 9 (3): 169-74. https://doi.org/10.34084/bshr.1760448.
EndNote
Altunçekiç Yildirim A, Işikli Ş, Kurt C, Öztürk Çerik H (01 Aralık 2025) Investigation of Seroprevalence of Vaccine-Preventable Diseases in Medical School Students. Journal of Biotechnology and Strategic Health Research 9 3 169–174.
IEEE
[1]A. Altunçekiç Yildirim, Ş. Işikli, C. Kurt, ve H. Öztürk Çerik, “Investigation of Seroprevalence of Vaccine-Preventable Diseases in Medical School Students”, J Biotechnol and Strategic Health Res, c. 9, sy 3, ss. 169–174, Ara. 2025, doi: 10.34084/bshr.1760448.
ISNAD
Altunçekiç Yildirim, Arzu - Işikli, Şeyma - Kurt, Celali - Öztürk Çerik, Hatun. “Investigation of Seroprevalence of Vaccine-Preventable Diseases in Medical School Students”. Journal of Biotechnology and Strategic Health Research 9/3 (01 Aralık 2025): 169-174. https://doi.org/10.34084/bshr.1760448.
JAMA
1.Altunçekiç Yildirim A, Işikli Ş, Kurt C, Öztürk Çerik H. Investigation of Seroprevalence of Vaccine-Preventable Diseases in Medical School Students. J Biotechnol and Strategic Health Res. 2025;9:169–174.
MLA
Altunçekiç Yildirim, Arzu, vd. “Investigation of Seroprevalence of Vaccine-Preventable Diseases in Medical School Students”. Journal of Biotechnology and Strategic Health Research, c. 9, sy 3, Aralık 2025, ss. 169-74, doi:10.34084/bshr.1760448.
Vancouver
1.Arzu Altunçekiç Yildirim, Şeyma Işikli, Celali Kurt, Hatun Öztürk Çerik. Investigation of Seroprevalence of Vaccine-Preventable Diseases in Medical School Students. J Biotechnol and Strategic Health Res. 01 Aralık 2025;9(3):169-74. doi:10.34084/bshr.1760448